-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Compass Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
- Compass Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$15M, a 12.8% decline year-over-year.
- Compass Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$55.1M, a 13.6% decline year-over-year.
- Compass Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$50.4M, a 20.9% decline from 2022.
- Compass Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$41.7M, a 49.1% increase from 2021.
- Compass Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$81.9M, a 194% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)